Epigenetic Regulation of Macrophage Polarization in Cardiovascular Diseases

Sumra Komal1, Sheng-Na Han1, Liu-Gen Cui1

  • 1Department of Pharmacology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, China.

Insights

Epigenetic modifications influence macrophage polarization, a key factor in cardiovascular diseases (CVDs). Understanding these changes offers potential for new epigenetic therapies to combat heart disease progression and mortality.

Area of Science:

  • Cardiovascular biology
  • Epigenetics
  • Immunology

Background:

  • Cardiovascular diseases (CVDs) are a major global health concern, leading to significant hospitalization and mortality.
  • Chronic inflammation and macrophage infiltration are critical in CVD initiation and progression.
  • Epigenetic modifications regulate cardiomyocyte functions and macrophage polarization, impacting cardiac disease development.

Purpose of the Study:

  • To review key epigenetic modifications influencing macrophage polarization in CVDs.
  • To explore the role of these modifications in cardiac disease pathophysiology.
  • To highlight potential epigenetic therapies for CVDs.

Main Methods:

  • Literature review of recent data on epigenetic modifications and CVDs.
  • Analysis of the role of DNA methylation, histone modifications, and RNA modifications.
  • Examination of cardiac macrophage polarization and its contribution to disease.

Main Results:

  • Epigenetic modifications significantly impact cardiomyocyte functions and macrophage polarization.
  • These modifications are involved in inflammatory responses, tissue repair, and remodeling in the context of CVDs.
  • Specific epigenetic mechanisms contribute to the pathophysiology of atherosclerosis, myocardial injury, and heart failure.

Conclusions:

  • Epigenetic modifications are crucial regulators in the development and progression of cardiovascular diseases.
  • Targeting epigenetic mechanisms in cardiac macrophages presents a promising therapeutic strategy.
  • Further research into epigenetic therapies could lead to advanced treatments for CVDs.